Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ocugen Inc (OCGN)
:OCGN
Holding OCGN?
Track your performance easily
OCGN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.49 - $2.11
Previous CloseN/A
Volume1.89M
Average Volume (3M)5.56M
Market Cap
$213.63M
Enterprise Value$244.09M
Total Cash (Recent Filing)$31.91M
Total Debt (Recent Filing)$178.00K
Price to Earnings (P/E)―
Beta1.90
Next Earnings
Mar 28, 2025EPS Estimate
-0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.17
Shares Outstanding291,320,280
10 Day Avg. Volume5,432,799
30 Day Avg. Volume5,555,570
Standard Deviation0.96
R-Squared0.04
Alpha0.11
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)22.77
Price to Cash Flow (P/CF)-4.70
P/FCF Ratio0.00
Enterprise Value/Market Cap1.14
Enterprise Value/Revenue26.17
Enterprise Value/Gross Profit40.44
Enterprise Value/Ebitda-5.17
Forecast
1Y Price Target
$6.33Price Target Upside779.17% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Ocugen News
PremiumCompany Announcements
Ocugen Appoints Ramesh Ramachandran as Financial Officer
PremiumCompany Announcements
Ocugen to Present Innovations at Nasdaq Clinical ShowcaseOwnership Overview
1.16% Insiders
8.01% Mutual Funds
0.05% Other Institutional Investors
81.13% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
OCGN FAQ
What was Ocugen Inc’s price range in the past 12 months?
Ocugen Inc lowest stock price was $0.49 and its highest was $2.10 in the past 12 months.
What is Ocugen Inc’s market cap?
Ocugen Inc’s market cap is $213.63M.
When is Ocugen Inc’s upcoming earnings report date?
Ocugen Inc’s upcoming earnings report date is Mar 28, 2025 which is in 69 days.
How were Ocugen Inc’s earnings last quarter?
Ocugen Inc released its earnings results on Nov 08, 2024. The company reported -$0.05 earnings per share for the quarter, beating the consensus estimate of -$0.055 by $0.005.
Is Ocugen Inc overvalued?
According to Wall Street analysts Ocugen Inc’s price is currently Undervalued.
Does Ocugen Inc pay dividends?
Ocugen Inc does not currently pay dividends.
What is Ocugen Inc’s EPS estimate?
Ocugen Inc’s EPS estimate is -0.06.
How many shares outstanding does Ocugen Inc have?
Ocugen Inc has 291,320,280 shares outstanding.
What happened to Ocugen Inc’s price movement after its last earnings report?
Ocugen Inc reported an EPS of -$0.05 in its last earnings report, beating expectations of -$0.055. Following the earnings report the stock price went down -8.333%.
Which hedge fund is a major shareholder of Ocugen Inc?
Currently, no hedge funds are holding shares in OCGN
---
Ocugen Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$6.33 (779.17% Upside)
$6.33 (779.17% Upside)
Blogger Sentiment
Bullish
OCGN Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 2.5M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $31.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.2%
Last 30 Days ▲ 1.7%
Last 30 Days ▲ 1.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
27.67%
12-Months-Change
Fundamentals
Return on Equity
-103.30%
Trailing 12-Months
Asset Growth
-17.07%
Trailing 12-Months
Company Description
Ocugen Inc
Ocugen, Inc. engages in the development and commercialization of therapies for eye diseases. Its pipeline of therapies includes OCU400, OCU410, OCU200, OCU100, and OCU300. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA.
---
OCGN Company Deck
---
OCGN Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant clinical and regulatory advancements, successful financing, and positive safety profiles for Ocugen's gene therapy programs. Despite stable operating expenses and cash position, the strategic achievements suggest confidence in Ocugen's future potential.Read More>---
OCGN Stock 12 Month Forecast
Average Price Target
$6.33
▲(779.17% Upside)
Technical Analysis
ADMA Biologics
―
Annovis Bio
―
Capricor Therapeutics
―
Rigel
―
Inovio Pharmaceuticals
―
Merck & Company
―
Best Analysts Covering OCGN
1 Year
1 Year Success Rate
6/17 ratings generated profit
1 Year Average Return
+19.70%
reiterated a buy rating 5 days ago
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 35.29% of your transactions generating a profit, with an average return of +19.70% per trade.
---